IDXX IDEXX Laboratories Inc
- 516.920
- -1.020-0.20%
IDEXX Laboratories Inc News
IDEXX Laboratories Inc(IDXX.US) Director Sells US$108.16K in Common Stock
$IDEXX Laboratories Inc(IDXX.US)$ Director Claflin Bruce L. sold 200 shares of common stock on May 17, 2024 at an average price of $540.8 for a total value of $108.16K.Source: Announcement What is sta
$100 Invested In This Stock 15 Years Ago Would Be Worth $2,500 Today
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 11.59% on an annualized basis producing an average annual return of 24.04%. Currently, IDEXX Laboratories has a m
IDEXX (IDXX) Witnesses Rising Expenses, Currency Issues
IDEXX Laboratories' IDXX business has been suffering due to complex macroeconomic conditions and unfavorable currency movement.
Form 144 | IDEXX Laboratories Inc(IDXX.US) Director Proposes to Sell 108.16K in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $IDEXX Laboratories Inc(IDXX.US)$ Director Claflin Bruce L. intends to sell 200 shares of its common stock on May 17, with a total market value of approximately $108.16
S&P 500, Nasdaq 100, Dow Jones Shatter Record Highs In Unstoppable Bull Market Rally
The S&P 500, Nasdaq 100 and Dow Jones Industrial Average indices all shattered fresh all-time highs Wednesday, driven by a benign inflation report that boosted risk sentiment among bullish investors.T
IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day
IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon, Executive Vice President and Chief Financial Officer, and Michael Lane, Executive Vice President,
IDEXX Labs Is Maintained at Overweight by Morgan Stanley
IDEXX Labs Is Maintained at Overweight by Morgan Stanley
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620
IDEXX Laboratories (IDXX) has an average outperform rating and a price target range of $400 to $641, according to analysts polled by Capital IQ. Price: 500.30, Change: -2.72, Percent Change: -0.54
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Potentially Undervalued?
Let's talk about the popular IDEXX Laboratories, Inc. (NASDAQ:IDXX). The company's shares saw significant share price movement during recent months on the NASDAQGS, rising to highs of US$577 and f
U.S. Pledges Nearly $200M to Prevent Bird Flu Spread on Dairy Farms
IDEXX Laboratories (NASDAQ:IDXX) Knows How To Allocate Capital
23 Most Profitable Stocks of the Last 12 Months
In this article, we discuss the 23 most profitable stocks of the last 12 months.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript
IDEXX Labs Is Maintained at Overweight by Barclays
IDEXX Labs Is Maintained at Overweight by Barclays
IDEXX Labs Price Target Cut to $570.00/Share From $655.00 by Barclays
IDEXX Labs Price Target Cut to $570.00/Share From $655.00 by Barclays
Express News | Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $570
IDEXX Laboratories Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 20.41% Barclays $655 → $570 Maintains Overweight 02/06/2024 33.09% JP Morgan $600 → $630 Mainta
Redburn Atlantic Adjusts Price Target on IDEXX Laboratories to $500 From $460
IDEXX Laboratories (IDXX) has an average outperform rating and price target range of $400 to $653, according to analysts polled by Capital IQ. Price: 470.71, Change: +2.67, Percent Change: +0.57
Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com
By Josh Nathan-Kazis Zoetis reported financial results for the first quarter that were slightly better than Wall Street expected as worries about its new pain medicines for dogs and cats continue to
Express News | IDEXX Laboratories, Inc. : Barclays Cuts Target Price to $570 From $655
Analysis
Price Target
No Data
